Sleep loss is a risk factor for type 2 diabetes, shows study

Credit: Andrea Piacquadio / Pexels.

In Australia, almost one million adults have type 2 diabetes. Globally, type 2 diabetes affects more than 422 million people.

In a study from the University of South Australia, scientists suggest people prioritize a good night’s sleep.

They found that troubled sleep may be linked to risk factors for type 2 diabetes.

They showed that people who reported trouble sleeping were on average more likely to have indicators of poor cardiometabolic health—inflammatory markers, cholesterol, and body weight—which can contribute to type 2 diabetes.

The team says different aspects of sleep are associated with risk factors for diabetes.

In this study, they examined the association between different aspects of sleep, and risk factors for diabetes, and found a connection between those who had troubled sleep and those who were at risk of type 2 diabetes.

The researchers assessed more than 1,000 Australian adults with a median age of 44.8 years.

They examined a range of sleep characteristics: self-report trouble sleeping, duration, timing, efficiency, and day-to-day sleep length variability.

They found people who reported having trouble sleeping were also more likely to have a higher body mass index, as well as blood markers of cholesterol and inflammation.

The team says more research is needed, but as this study shows, it’s important to think about sleep as a whole, not just as one aspect.

If you care about sleep, please read studies about drugs that can treat sleep loss and insomnia, and short sleep duration may increase your risk of metabolic syndrome.

For more information about sleep, please see recent studies that 7 hours of sleep is best for people in middle and old age, and results showing common anxiety and sleep drugs may harm your cognitive functions.

The study was conducted by Dr. Lisa Matricciani et al and published in The Science of Diabetes Self-Management and Care.

Copyright © 2022 Knowridge Science Report. All rights reserved.